✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Accretion Pharmaceuticals Ltd.

ACCPL

Market Cap
₹72 Cr.
P/E
10.60

Accretion Pharmaceuticals Ltd.

  • Accretion Pharma.
  • Sakar Healthcare
  • Lincoln Pharma
FAQs on Accretion Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Accretion Pharma. is 10.95

View FAQ's On Business
Growth Table
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Balance Sheet
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Cash Flow
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Quarterly Results
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Accretion Pharmaceuticals Ltd. Financials

Balance sheet of Accretion Pharma. is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Accretion Pharma. is increasing.
Latest net debt of Accretion Pharma. is ₹14.05 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹13.39 Crs.

Yes, profit is increasing.
The profit of Accretion Pharma. is ₹5.82 Crs for TTM, ₹3.88 Crs for Mar 2024 and ₹0 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Accretion Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

NA

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech